What Jensen Huang Just Said Could Lift Tesla Beyond SpaceX
NVIDIA CEO Jensen Huang signaled a bigger AI opportunity ahead for Tesla, suggesting the EV maker could outgrow its c...
Which Is Better Risk Parity Or Index Funds
Assess whether Risk Parity or index funds better suit your retirement plan by examining diversification, cost, and potential risk/return trade-offs.
27,926 articles
PepsiCo’s 3.9% Yield Safe-Haven Lands in Markets Today
Investors are turning to PepsiCo for steady income as the 3.9% yield still looks like a safe-haven amid volatile mark...
American Airlines Jumps, United Climbs on Fuel Relief
U.S. airline stocks rise on easing fuel costs, led by American Airlines and United, as crude prices slip and margins ...
Strategist Says Tech Is ‘Completely Underappreciated’ Now
A veteran market strategist argues Big Tech is underappreciated as earnings grow and capital spending remains durable...
Meta’s $125 Billion Push Shifts Wall Street Outlook
Meta Platforms is dialing up AI infrastructure spending, guiding 2026 capex to $125-145 billion after a strong Q1. Th...
T.I. Targets Cent with New Diss Tracks as Let Em Know Climbs
When a feud becomes a marketing engine, money talks louder than records. This feature examines how T.I. targets Cent ...
Minneapolis Report Details Much Toll on Jobs and Growth
A new Minneapolis Fed beige book reveals how immigration enforcement pressured hiring, cut ESL enrollments, and tight...
Invested $1,000 Altria Philip: A Ten-Year Review
Two tobacco giants show divergent paths over 10 years, with dividend income boosting returns for both. Here's what ha...
NVIDIA: The Party Going, but How Much Longer for Investors?
NVIDIA posted blockbuster results that reinforce its AI data center leadership, but the stock faces a rocky road as h...
Moviegoers Still Hungry Sanitized Biopic Tops Box Office
The Michael biopic reclaimed the top spot with a domestic 26.1M, while Prada 2 trailed in second. New releases also j...
CVS to Cover Lilly’s GLP-1 Medications, Expanding Access
CVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
Nearly 700% This Year: Is Sandisk Stock Still Worth Buying?
Sandisk stock has surged dramatically this year, but a rally this strong begs tough questions. This guide breaks down...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status